Atlas Trials

A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer

Clinical trial NCT06196736 · RECRUITING

Trial details

NCT number
NCT06196736
Sponsor
Mabwell (Shanghai) Bioscience Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Urothelial Carcinoma
Start date
2023-12-29
Primary completion
2026-09-01
Enrollment
432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.